Clinical Pharmacology & Therapeutics - AOP - nature.com science feeds Clinical Pharmacology & Therapeutics, the most cited journal publishing primary investigation in pharmacology and pharmacy, is the authoritative, cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy and evaluation of therapeutics. http://www.nature.com/clpt/journal/vaop/ncurrent/rss.rdf Nature Publishing Group en Copyright © Nature Publishing Group Clinical Pharmacology & Therapeutics 0009-9236 Copyright © Nature Publishing Group permissions@nature.com Clinical Pharmacology & Therapeutics http://www.nature.com/aj/images/logos_b_o_w/clpt.gif http://www.nature.com/clpt/ Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study http://feeds.nature.com/~r/clpt/rss/aop/~3/e73C4ya4_80/sj.clpt.6100514 Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Clinical Pharmacology & Therapeutics advance online publication, February 20, 2008. doi:10.1038/sj.clpt.6100514

Authors: MF Hebert, TR Easterling, B Kirby, DB Carr, ML Buchanan, T Rutherford, KE Thummel, DP Fishbein & JD Unadkat

]]> Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study MF Hebert TR Easterling B Kirby DB Carr ML Buchanan T Rutherford KE Thummel DP Fishbein JD Unadkat doi:10.1038/sj.clpt.6100514 Clinical Pharmacology & Therapeutics advance online publication, February 20, 2008 200-02-20 Clinical Pharmacology & Therapeutics February 20, 2008 10.1038/sj.clpt.6100514 http://dx.doi.org/10.1038/sj.clpt.6100514 aop current http://dx.doi.org/10.1038/sj.clpt.6100514 Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready? http://feeds.nature.com/~r/clpt/rss/aop/~3/P6stczGm0M8/sj.clpt.6100517 Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready?

Clinical Pharmacology & Therapeutics advance online publication, February 13, 2008. doi:10.1038/sj.clpt.6100517

Authors: AE Shields & C Lerman

]]> Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready? AE Shields C Lerman doi:10.1038/sj.clpt.6100517 Clinical Pharmacology & Therapeutics advance online publication, February 13, 2008 200-02-13 Clinical Pharmacology & Therapeutics February 13, 2008 10.1038/sj.clpt.6100517 http://dx.doi.org/10.1038/sj.clpt.6100517 aop current http://dx.doi.org/10.1038/sj.clpt.6100517 Transporters for Drug Delivery and as Drug Targets in Parasitic Protozoa http://feeds.nature.com/~r/clpt/rss/aop/~3/9Xqe7dG_d00/clpt.2009.116 Transporters for Drug Delivery and as Drug Targets in Parasitic Protozoa

Clinical Pharmacology & Therapeutics advance online publication, July 1, 2009. doi:10.1038/clpt.2009.116

Author: S M Landfear

]]> Transporters for Drug Delivery and as Drug Targets in Parasitic Protozoa S M Landfear doi:10.1038/clpt.2009.116 Clinical Pharmacology & Therapeutics advance online publication, July 1, 2009 2009-07-01 Clinical Pharmacology & Therapeutics July 1, 2009 10.1038/clpt.2009.116 http://dx.doi.org/10.1038/clpt.2009.116 aop current http://dx.doi.org/10.1038/clpt.2009.116 Rupatadine and Heart Rhythm Disturbances http://feeds.nature.com/~r/clpt/rss/aop/~3/h4TqRAdStwQ/clpt.2009.118 Rupatadine and Heart Rhythm Disturbances

Clinical Pharmacology & Therapeutics advance online publication, September 2, 2009. doi:10.1038/clpt.2009.118

Authors: R Fité & J Borja

]]> Rupatadine and Heart Rhythm Disturbances R Fité J Borja doi:10.1038/clpt.2009.118 Clinical Pharmacology & Therapeutics advance online publication, September 2, 2009 2009-07-02 Clinical Pharmacology & Therapeutics September 2, 2009 10.1038/clpt.2009.118 http://dx.doi.org/10.1038/clpt.2009.118 aop current http://dx.doi.org/10.1038/clpt.2009.118 Response to “Rupatadine and Heart Rhythm Disturbances” http://feeds.nature.com/~r/clpt/rss/aop/~3/QuabGy3CN0I/clpt.2009.157 Response to “Rupatadine and Heart Rhythm Disturbances”

Clinical Pharmacology & Therapeutics advance online publication, September 2, 2009. doi:10.1038/clpt.2009.157

Authors: A Carvajal, D Macías, I Salado, M Sáinz, S Ortega, C Campo, J García del Pozo, L H Martín Arias, A Velasco, S Gonçalves, R Pombal & R Carmona

]]> Response to “Rupatadine and Heart Rhythm Disturbances” A Carvajal D Macías I Salado M Sáinz S Ortega C Campo J García del Pozo L H Martín Arias A Velasco S Gonçalves R Pombal R Carmona doi:10.1038/clpt.2009.157 Clinical Pharmacology & Therapeutics advance online publication, September 2, 2009 2009-07-02 Clinical Pharmacology & Therapeutics September 2, 2009 10.1038/clpt.2009.157 http://dx.doi.org/10.1038/clpt.2009.157 aop current http://dx.doi.org/10.1038/clpt.2009.157 Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study http://feeds.nature.com/~r/clpt/rss/aop/~3/S_Y2G_E-Xk8/clpt.2009.176 Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study

Clinical Pharmacology & Therapeutics advance online publication, September 30, 2009. doi:10.1038/clpt.2009.176

Authors: K Zhou, L Donnelly, L Burch, R Tavendale, A S F Doney, G Leese, A T Hattersley, M I McCarthy, A D Morris, C C Lang, C N A Palmer & E R Pearson

]]> Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study K Zhou L Donnelly L Burch R Tavendale A S F Doney G Leese A T Hattersley M I McCarthy A D Morris C C Lang C N A Palmer E R Pearson doi:10.1038/clpt.2009.176 Clinical Pharmacology & Therapeutics advance online publication, September 30, 2009 2009-07-30 Clinical Pharmacology & Therapeutics September 30, 2009 10.1038/clpt.2009.176 http://dx.doi.org/10.1038/clpt.2009.176 aop current http://dx.doi.org/10.1038/clpt.2009.176 Pharmacokinetics of Sulfadoxine and Pyrimethamine in Intermittent Preventive Treatment of Malaria in Pregnancy http://feeds.nature.com/~r/clpt/rss/aop/~3/47VGZkGRnbo/clpt.2009.177 Pharmacokinetics of Sulfadoxine and Pyrimethamine in Intermittent Preventive Treatment of Malaria in Pregnancy

Clinical Pharmacology & Therapeutics advance online publication, September 23, 2009. doi:10.1038/clpt.2009.177

Authors: M M Nyunt, I Adam, K Kayentao, J van Dijk, P Thuma, K Mauff, F Little, Y Cassam, E Guirou, B Traore, O Doumbo, D Sullivan, P Smith & K I Barnes

]]> Pharmacokinetics of Sulfadoxine and Pyrimethamine in Intermittent Preventive Treatment of Malaria in Pregnancy M M Nyunt I Adam K Kayentao J van Dijk P Thuma K Mauff F Little Y Cassam E Guirou B Traore O Doumbo D Sullivan P Smith K I Barnes doi:10.1038/clpt.2009.177 Clinical Pharmacology & Therapeutics advance online publication, September 23, 2009 2009-07-23 Clinical Pharmacology & Therapeutics September 23, 2009 10.1038/clpt.2009.177 http://dx.doi.org/10.1038/clpt.2009.177 aop current http://dx.doi.org/10.1038/clpt.2009.177 Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients http://feeds.nature.com/~r/clpt/rss/aop/~3/WvR0fgmrleU/clpt.2009.178 Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients

Clinical Pharmacology & Therapeutics advance online publication, September 30, 2009. doi:10.1038/clpt.2009.178

Authors: E Pautas, C Moreau, I Gouin-Thibault, J-L Golmard, I Mahé, C Legendre, E Taillandier-Hériche, B Durand-Gasselin, A-M Houllier, P Verrier, P Beaune, M-A Loriot & V Siguret

]]> Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients E Pautas C Moreau I Gouin-Thibault J-L Golmard I Mahé C Legendre E Taillandier-Hériche B Durand-Gasselin A-M Houllier P Verrier P Beaune M-A Loriot V Siguret doi:10.1038/clpt.2009.178 Clinical Pharmacology & Therapeutics advance online publication, September 30, 2009 2009-07-30 Clinical Pharmacology & Therapeutics September 30, 2009 10.1038/clpt.2009.178 http://dx.doi.org/10.1038/clpt.2009.178 aop current http://dx.doi.org/10.1038/clpt.2009.178 UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo http://feeds.nature.com/~r/clpt/rss/aop/~3/iAk0GTadxVg/clpt.2009.181 UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo

Clinical Pharmacology & Therapeutics advance online publication, September 30, 2009. doi:10.1038/clpt.2009.181

Authors: S Riedmaier, K Klein, U Hofmann, J E Keskitalo, P J Neuvonen, M Schwab, M Niemi & U M Zanger

]]> UDP-Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo S Riedmaier K Klein U Hofmann J E Keskitalo P J Neuvonen M Schwab M Niemi U M Zanger doi:10.1038/clpt.2009.181 Clinical Pharmacology & Therapeutics advance online publication, September 30, 2009 2009-07-30 Clinical Pharmacology & Therapeutics September 30, 2009 10.1038/clpt.2009.181 http://dx.doi.org/10.1038/clpt.2009.181 aop current http://dx.doi.org/10.1038/clpt.2009.181 A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients http://feeds.nature.com/~r/clpt/rss/aop/~3/81g2v7T-CAY/clpt.2009.185 A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients

Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009. doi:10.1038/clpt.2009.185

Authors: E Ramirez, A J Carcas, A M Borobia, S H Lei, E Piñana, S Fudio & J Frias

]]> A Pharmacovigilance Program From Laboratory Signals for the Detection and Reporting of Serious Adverse Drug Reactions in Hospitalized Patients E Ramirez A J Carcas A M Borobia S H Lei E Piñana S Fudio J Frias doi:10.1038/clpt.2009.185 Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009 200-11-04 Clinical Pharmacology & Therapeutics November 4, 2009 10.1038/clpt.2009.185 http://dx.doi.org/10.1038/clpt.2009.185 aop current http://dx.doi.org/10.1038/clpt.2009.185 Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects http://feeds.nature.com/~r/clpt/rss/aop/~3/acAsddahUns/clpt.2009.186 Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects

Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009. doi:10.1038/clpt.2009.186

Authors: D Schmidl, E Polska, B Kiss, S Sacu, G Garhofer & L Schmetterer

]]> Ocular Hemodynamic Effects of Nitrovasodilators in Healthy Subjects D Schmidl E Polska B Kiss S Sacu G Garhofer L Schmetterer doi:10.1038/clpt.2009.186 Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009 200-11-04 Clinical Pharmacology & Therapeutics November 4, 2009 10.1038/clpt.2009.186 http://dx.doi.org/10.1038/clpt.2009.186 aop current http://dx.doi.org/10.1038/clpt.2009.186 Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia http://feeds.nature.com/~r/clpt/rss/aop/~3/s-5Lthpaijc/clpt.2009.194 Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia

Clinical Pharmacology & Therapeutics advance online publication, November 11, 2009. doi:10.1038/clpt.2009.194

Authors: B G Oertel, L Felden, P V Tran, M H Bradshaw, M S Angst, H Schmidt, S Johnson, J J Greer, G Geisslinger, M A Varney & J Lötsch

]]> Selective Antagonism of Opioid-Induced Ventilatory Depression by an Ampakine Molecule in Humans Without Loss of Opioid Analgesia B G Oertel L Felden P V Tran M H Bradshaw M S Angst H Schmidt S Johnson J J Greer G Geisslinger M A Varney J Lötsch doi:10.1038/clpt.2009.194 Clinical Pharmacology & Therapeutics advance online publication, November 11, 2009 200-11-11 Clinical Pharmacology & Therapeutics November 11, 2009 10.1038/clpt.2009.194 http://dx.doi.org/10.1038/clpt.2009.194 aop current http://dx.doi.org/10.1038/clpt.2009.194 Transporter Pharmacogenetics and Statin Toxicity http://feeds.nature.com/~r/clpt/rss/aop/~3/z6uL2b7WqE4/clpt.2009.197 Transporter Pharmacogenetics and Statin Toxicity

Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009. doi:10.1038/clpt.2009.197

Author: M Niemi

]]> Transporter Pharmacogenetics and Statin Toxicity M Niemi doi:10.1038/clpt.2009.197 Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009 200-11-04 Clinical Pharmacology & Therapeutics November 4, 2009 10.1038/clpt.2009.197 http://dx.doi.org/10.1038/clpt.2009.197 aop current http://dx.doi.org/10.1038/clpt.2009.197 Comparison of Critical Drug–Drug Interaction Listings: The Department of Veterans Affairs Medical System and Standard Reference Compendia http://feeds.nature.com/~r/clpt/rss/aop/~3/JP_kz9-sxLs/clpt.2009.198 Comparison of Critical Drug–Drug Interaction Listings: The Department of Veterans Affairs Medical System and Standard Reference Compendia

Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009. doi:10.1038/clpt.2009.198

Authors: E L Olvey, S Clauschee & D C Malone

]]> Comparison of Critical Drug–Drug Interaction Listings: The Department of Veterans Affairs Medical System and Standard Reference Compendia E L Olvey S Clauschee D C Malone doi:10.1038/clpt.2009.198 Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009 200-11-04 Clinical Pharmacology & Therapeutics November 4, 2009 10.1038/clpt.2009.198 http://dx.doi.org/10.1038/clpt.2009.198 aop current http://dx.doi.org/10.1038/clpt.2009.198 Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants http://feeds.nature.com/~r/clpt/rss/aop/~3/9YuEuGL5oUc/clpt.2009.200 Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants

Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009. doi:10.1038/clpt.2009.200

Authors: D K Benjamin, P B Smith, A Arrieta, L Castro, P J Sánchez, D Kaufman, L J Arnold, L L Kovanda, T Sawamoto, D N Buell, W W Hope & T J Walsh

]]> Safety and Pharmacokinetics of Repeat-Dose Micafungin in Young Infants D K Benjamin P B Smith A Arrieta L Castro P J Sánchez D Kaufman L J Arnold L L Kovanda T Sawamoto D N Buell W W Hope T J Walsh doi:10.1038/clpt.2009.200 Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009 200-11-04 Clinical Pharmacology & Therapeutics November 4, 2009 10.1038/clpt.2009.200 http://dx.doi.org/10.1038/clpt.2009.200 aop current http://dx.doi.org/10.1038/clpt.2009.200 The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics http://feeds.nature.com/~r/clpt/rss/aop/~3/iJwrdPBblIs/clpt.2009.205 The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics

Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009. doi:10.1038/clpt.2009.205

Authors: N Picard, S W Yee, J-B Woillard, Y Lebranchu, Y Le Meur, K M Giacomini & P Marquet

]]> The Role of Organic Anion–Transporting Polypeptides and Their Common Genetic Variants in Mycophenolic Acid Pharmacokinetics N Picard S W Yee J-B Woillard Y Lebranchu Y Le Meur K M Giacomini P Marquet doi:10.1038/clpt.2009.205 Clinical Pharmacology & Therapeutics advance online publication, November 4, 2009 200-11-04 Clinical Pharmacology & Therapeutics November 4, 2009 10.1038/clpt.2009.205 http://dx.doi.org/10.1038/clpt.2009.205 aop current http://dx.doi.org/10.1038/clpt.2009.205 Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity http://feeds.nature.com/~r/clpt/rss/aop/~3/MkxgpyYXPsk/clpt.2009.206 Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity

Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009. doi:10.1038/clpt.2009.206

Authors: V Hafner, M Jäger, A-K Matthée, R Ding, J Burhenne, W E Haefeli & G Mikus

]]> Effect of Simultaneous Induction and Inhibition of CYP3A by St John's Wort and Ritonavir on CYP3A Activity V Hafner M Jäger A-K Matthée R Ding J Burhenne W E Haefeli G Mikus doi:10.1038/clpt.2009.206 Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009 200-11-18 Clinical Pharmacology & Therapeutics November 18, 2009 10.1038/clpt.2009.206 http://dx.doi.org/10.1038/clpt.2009.206 aop current http://dx.doi.org/10.1038/clpt.2009.206 Clinical Pharmacokinetics of the BCR–ABL Tyrosine Kinase Inhibitor Nilotinib http://feeds.nature.com/~r/clpt/rss/aop/~3/NxerSQj85ok/clpt.2009.208 Clinical Pharmacokinetics of the BCR–ABL Tyrosine Kinase Inhibitor Nilotinib

Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009. doi:10.1038/clpt.2009.208

Authors: C Tanaka, O Q P Yin, V Sethuraman, T Smith, X Wang, K Grouss, H Kantarjian, F Giles, O G Ottmann, L Galitz & H Schran

]]> Clinical Pharmacokinetics of the BCR–ABL Tyrosine Kinase Inhibitor Nilotinib C Tanaka O Q P Yin V Sethuraman T Smith X Wang K Grouss H Kantarjian F Giles O G Ottmann L Galitz H Schran doi:10.1038/clpt.2009.208 Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009 200-11-18 Clinical Pharmacology & Therapeutics November 18, 2009 10.1038/clpt.2009.208 http://dx.doi.org/10.1038/clpt.2009.208 aop current http://dx.doi.org/10.1038/clpt.2009.208 Transporters as Drug Targets: Discovery and Development of NPC1L1 Inhibitors http://feeds.nature.com/~r/clpt/rss/aop/~3/yL0Fp1i43KA/clpt.2009.209 Transporters as Drug Targets: Discovery and Development of NPC1L1 Inhibitors

Clinical Pharmacology & Therapeutics advance online publication, November 11, 2009. doi:10.1038/clpt.2009.209

Authors: J L Betters & L Yu

]]> Transporters as Drug Targets: Discovery and Development of NPC1L1 Inhibitors J L Betters L Yu doi:10.1038/clpt.2009.209 Clinical Pharmacology & Therapeutics advance online publication, November 11, 2009 200-11-11 Clinical Pharmacology & Therapeutics November 11, 2009 10.1038/clpt.2009.209 http://dx.doi.org/10.1038/clpt.2009.209 aop current http://dx.doi.org/10.1038/clpt.2009.209 Delays in New Drug Applications in Japan and Industrial R&D Strategies http://feeds.nature.com/~r/clpt/rss/aop/~3/_altuQeWjLg/clpt.2009.215 Delays in New Drug Applications in Japan and Industrial R&D Strategies

Clinical Pharmacology & Therapeutics advance online publication, November 25, 2009. doi:10.1038/clpt.2009.215

Authors: Y Hirai, H Kinoshita, M Kusama, K Yasuda, Y Sugiyama & S Ono

]]> Delays in New Drug Applications in Japan and Industrial R&D Strategies Y Hirai H Kinoshita M Kusama K Yasuda Y Sugiyama S Ono doi:10.1038/clpt.2009.215 Clinical Pharmacology & Therapeutics advance online publication, November 25, 2009 200-11-25 Clinical Pharmacology & Therapeutics November 25, 2009 10.1038/clpt.2009.215 http://dx.doi.org/10.1038/clpt.2009.215 aop current http://dx.doi.org/10.1038/clpt.2009.215 High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases http://feeds.nature.com/~r/clpt/rss/aop/~3/bRPcNj8GqmA/clpt.2009.216 High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases

Clinical Pharmacology & Therapeutics advance online publication, November 11, 2009. doi:10.1038/clpt.2009.216

Authors: A L Zackrisson, B Lindblom & J Ahlner

]]> High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases A L Zackrisson B Lindblom J Ahlner doi:10.1038/clpt.2009.216 Clinical Pharmacology & Therapeutics advance online publication, November 11, 2009 200-11-11 Clinical Pharmacology & Therapeutics November 11, 2009 10.1038/clpt.2009.216 http://dx.doi.org/10.1038/clpt.2009.216 aop current http://dx.doi.org/10.1038/clpt.2009.216 The Pharmacogenomics of Membrane Transporters Project: Research at the Interface of Genomics and Transporter Pharmacology http://feeds.nature.com/~r/clpt/rss/aop/~3/JJXZHdbzpBE/clpt.2009.226 The Pharmacogenomics of Membrane Transporters Project: Research at the Interface of Genomics and Transporter Pharmacology

Clinical Pharmacology & Therapeutics advance online publication, November 25, 2009. doi:10.1038/clpt.2009.226

Authors: D L Kroetz, S W Yee & K M Giacomini

]]> The Pharmacogenomics of Membrane Transporters Project: Research at the Interface of Genomics and Transporter Pharmacology D L Kroetz S W Yee K M Giacomini doi:10.1038/clpt.2009.226 Clinical Pharmacology & Therapeutics advance online publication, November 25, 2009 200-11-25 Clinical Pharmacology & Therapeutics November 25, 2009 10.1038/clpt.2009.226 http://dx.doi.org/10.1038/clpt.2009.226 aop current http://dx.doi.org/10.1038/clpt.2009.226 Intravenous-to-Oral Switch in Anticancer Chemotherapy: A Focus on Docetaxel and Paclitaxel http://feeds.nature.com/~r/clpt/rss/aop/~3/2ZVRpCnAAsU/clpt.2009.233 Intravenous-to-Oral Switch in Anticancer Chemotherapy: A Focus on Docetaxel and Paclitaxel

Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009. doi:10.1038/clpt.2009.233

Authors: S L W Koolen, J H Beijnen & J H M Schellens

]]> Intravenous-to-Oral Switch in Anticancer Chemotherapy: A Focus on Docetaxel and Paclitaxel S L W Koolen J H Beijnen J H M Schellens doi:10.1038/clpt.2009.233 Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009 200-11-18 Clinical Pharmacology & Therapeutics November 18, 2009 10.1038/clpt.2009.233 http://dx.doi.org/10.1038/clpt.2009.233 aop current http://dx.doi.org/10.1038/clpt.2009.233 Drug Uptake Systems in Liver and Kidney: A Historic Perspective http://feeds.nature.com/~r/clpt/rss/aop/~3/ivJAkrxhpe0/clpt.2009.235 Drug Uptake Systems in Liver and Kidney: A Historic Perspective

Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009. doi:10.1038/clpt.2009.235

Author: B Hagenbuch

]]> Drug Uptake Systems in Liver and Kidney: A Historic Perspective B Hagenbuch doi:10.1038/clpt.2009.235 Clinical Pharmacology & Therapeutics advance online publication, November 18, 2009 200-11-18 Clinical Pharmacology & Therapeutics November 18, 2009 10.1038/clpt.2009.235 http://dx.doi.org/10.1038/clpt.2009.235 aop current http://dx.doi.org/10.1038/clpt.2009.235 Clinical Pharmacology and Dietary Supplements: An Evolving Relationship http://feeds.nature.com/~r/clpt/rss/aop/~3/u_FgM6Hw5Gg/clpt.2009.245 Clinical Pharmacology and Dietary Supplements: An Evolving Relationship

Clinical Pharmacology & Therapeutics advance online publication, November 25, 2009. doi:10.1038/clpt.2009.245

Author: B J Gurley

]]> Clinical Pharmacology and Dietary Supplements: An Evolving Relationship B J Gurley doi:10.1038/clpt.2009.245 Clinical Pharmacology & Therapeutics advance online publication, November 25, 2009 200-11-25 Clinical Pharmacology & Therapeutics November 25, 2009 10.1038/clpt.2009.245 http://dx.doi.org/10.1038/clpt.2009.245 aop current http://dx.doi.org/10.1038/clpt.2009.245